{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:54:38Z","timestamp":1790621678906,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/V013831\/1"],"award-info":[{"award-number":["BB\/V013831\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.omtn.2022.11.024","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T02:47:06Z","timestamp":1670208426000},"page":"29-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8093-8741","authenticated-orcid":false,"given":"John S.","family":"Tregoning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Stirling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie E.","family":"Flight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Blakney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Cunliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valarmathy","family":"Murugaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Shattock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2022.11.024_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtn.2022.11.024_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/cei.13517","article-title":"Vaccines for COVID-19","volume":"202","author":"Tregoning","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.omtn.2022.11.024_bib3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.11.024_bib4","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.11.024_bib5","doi-asserted-by":"crossref","first-page":"101262","DOI":"10.1016\/j.eclinm.2021.101262","article-title":"Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial","volume":"44","author":"Pollock","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.omtn.2022.11.024_bib6","unstructured":"Maruggi G, Ulmer JB, Rappuoli R, Yu D. Self-amplifying mRNA-Based Vaccine Technology and its Mode of Action. Springer Berlin; 1-40."},{"key":"10.1016\/j.omtn.2022.11.024_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.immuni.2020.03.017","article-title":"Distinct and orchestrated functions of RNA sensors in innate immunity","volume":"53","author":"Liu","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2022.11.024_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","article-title":"Complex modulation of cell type-specific signaling in response to type I interferons","volume":"25","author":"van Boxel-Dezaire","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2022.11.024_bib9","doi-asserted-by":"crossref","first-page":"113900","DOI":"10.1016\/j.addr.2021.113900","article-title":"Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across","volume":"176","author":"Minnaert","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2022.11.024_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/imm.12742","article-title":"Inflammatory responses to influenza vaccination at the extremes of age","volume":"151","author":"McDonald","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.omtn.2022.11.024_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2022.11.024_bib12","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1021\/acsnano.0c00326","article-title":"Big is beautiful: enhanced saRNA delivery and immunogenicity by a higher molecular weight, bioreducible, cationic polymer","volume":"14","author":"Blakney","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtn.2022.11.024_bib13","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.ymthe.2018.07.010","article-title":"A nanostructured lipid carrier for delivery of a replicating viral RNA provides single, low-dose protection against Zika","volume":"26","author":"Erasmus","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.11.024_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2021.08.029","article-title":"Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines","volume":"338","author":"Blakney","year":"2021","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtn.2022.11.024_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fimmu.2018.00126","article-title":"Mouse models of influenza infection with circulating strains to test seasonal vaccine efficacy. Original research frontiers in immunology","volume":"9","author":"Groves","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2022.11.024_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2013.05.007","article-title":"Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice","volume":"99","author":"Arimori","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.omtn.2022.11.024_bib17","doi-asserted-by":"crossref","first-page":"12713","DOI":"10.1128\/JVI.01675-10","article-title":"MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection","volume":"84","author":"Seo","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2022.11.024_bib18","doi-asserted-by":"crossref","first-page":"e100574","DOI":"10.1371\/journal.ppat.1005754","article-title":"RIG-I signaling is critical for efficient polyfunctional T\u00a0cell responses during influenza virus infection","volume":"12","author":"Kandasamy","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2022.11.024_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-017-0032-6","article-title":"Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines","volume":"2","author":"Lutz","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.omtn.2022.11.024_bib20","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","article-title":"Efficient targeting and activation of antigen-presenting cells in\u00a0vivo after modified mRNA vaccine administration in rhesus macaques","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.11.024_bib21","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.1601877","article-title":"Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design","volume":"198","author":"Pepini","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtn.2022.11.024_bib22","article-title":"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","author":"Ndeupen","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2022.11.024_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/vaccines8030433","article-title":"Lipid nanoparticle acts as a potential adjuvant for influenza split vaccine without inducing inflammatory responses","volume":"8","author":"Shirai","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.omtn.2022.11.024_bib24","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","article-title":"Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens","volume":"30","author":"Watson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2022.11.024_bib25","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2022.11.024_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.omtn.2019.08.001","article-title":"Expression kinetics and innate immune response after electroporation and LNP-mediated delivery of a self-amplifying mRNA in the skin","volume":"17","author":"Huysmans","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2022.11.024_bib27","doi-asserted-by":"crossref","first-page":"e1003118","DOI":"10.1371\/journal.ppat.1003118","article-title":"IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling","volume":"9","author":"Lazear","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2022.11.024_bib28","article-title":"Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2022.11.024_bib29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ymthe.2020.11.011","article-title":"Innate inhibiting proteins enhance expression and immunogenicity of self-amplifying RNA","volume":"29","author":"Blakney","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.11.024_bib30","doi-asserted-by":"crossref","first-page":"109504","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2022.11.024_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cyto.2017.08.009","article-title":"The synergistic effects of combining TLR ligand based adjuvants on the cytokine response are dependent upon p38\/JNK signalling","volume":"99","author":"Fischetti","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.omtn.2022.11.024_bib32","doi-asserted-by":"crossref","first-page":"e46149","DOI":"10.7554\/eLife.46149","article-title":"Identification of potential biomarkers of vaccine inflammation in mice","volume":"8","author":"McKay","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.omtn.2022.11.024_bib33","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1080\/21645515.2015.1070998","article-title":"Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques","volume":"11","author":"Veazey","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.omtn.2022.11.024_bib34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2022.11.024_bib35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.omtn.2021.03.008","article-title":"Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein","volume":"24","author":"Davies","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2022.11.024_bib36","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1084\/jem.20181899","article-title":"TLR8: No gain, no pain","volume":"215","author":"Barrat","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtn.2022.11.024_bib37","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.molimm.2009.11.003","article-title":"A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition","volume":"47","author":"Liu","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omtn.2022.11.024_bib38","doi-asserted-by":"crossref","first-page":"iqac004","DOI":"10.1093\/oxfimm\/iqac004","article-title":"Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets","volume":"3","author":"McKay","year":"2022","journal-title":"Oxford Open Immunol."},{"key":"10.1016\/j.omtn.2022.11.024_bib39","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1128\/JVI.00333-14","article-title":"Alpha\/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection","volume":"88","author":"Goritzka","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2022.11.024_bib40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2007.07.013","article-title":"Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses","volume":"27","author":"Kumagai","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2022.11.024_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cei.13234","article-title":"The impact of timing of maternal influenza immunization on infant antibody levels at birth","volume":"195","author":"Zhong","year":"2019","journal-title":"Clin. Exp. Immunol."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312200316X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312200316X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:34:54Z","timestamp":1761874494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312200316X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":41,"alternative-id":["S216225312200316X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2022.11.024","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2022.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}]}}